Kimitaka Saito, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 202 Newsome Dr, Marked Tree, AR 72365 Phone: 870-358-4355 Fax: 870-358-4357 |
News Archive
AstraZeneca today announced it has entered into a settlement agreement in its U.S. SEROQUEL XR patent infringement litigation against Handa Pharmaceuticals, LLC regarding Handa's proposed generic version of AstraZeneca's SEROQUEL XR extended-release tablets.
"World powers are moving slowly toward an accord on the strategy to be embraced at a looming United Nations summit aiming to get the lofty Millennium Development Goals [MDGs] back on track," Agence France-Presse writes in an article examining the ongoing debates over how best to achieve the MDGs before the 2015 deadline.
All cells have the ability to recycle unwanted or damaged proteins and reuse the building blocks as food. But cancer cells have ramped up the system, called autophagy, and rely on it to escape damage in the face of chemotherapy and other treatments. Now, researchers at the Perelman School of Medicine; the Abramson Cancer Center; and the School of Arts and Sciences, at the University of Pennsylvania, have developed a potent new drug that clogs up the recycling machinery and kills tumor cells in mouse models.
The Centers for Medicare & Medicaid Services (CMS) today announced that 121 hospitals in 25 states will begin receiving higher payments for patients who are discharged on or after April 1, 2004. The increases are due to the geographic reclassification of these hospitals under a special one-time-only provision in the recent Medicare modernization law. The new payments will be retroactive to April 1.
› Verified 8 days ago